Abstract:Uncovering the functionally essential variations related to tumorigenesis and tumor progression from cancer genomics data is still challenging due to the genetic diversity among patients, and extensive inter- and intra-tumoral heterogeneity at different levels of gene expression regulation, including but not limited to the genomic, epigenomic, and transcriptional levels. To minimize the impact of germline genetic heterogeneities, in this study, we establish multiple primary cultures from the primary and recurrent tumors of a single patient with hepatocellular carcinoma (HCC). Multi-omics sequencing was performed for these cultures that encompass the diversity of tumor cells from the same patient. Variations in the genome sequence, epigenetic modification, and gene expression are used to infer the phylogenetic relationships of these cell cultures. We find the discrepancy among the relationships revealed by single nucleotide variations (SNVs) and transcriptional/epigenomic profiles from the cell cultures. We fail to find overlap between sample-specific mutated genes and differentially expressed genes (DEGs), suggesting that most of the heterogeneous SNVs among tumor stages or lineages of the patient are functionally insignificant. Moreover, copy number alterations (CNAs) and DNA methylation variation within gene bodies, rather than promoters, are significantly correlated with gene expression variability among these cell cultures. Pathway analysis of CNA/DNA methylation-related genes indicates that a single cell clone from the recurrent tumor exhibits distinct cellular characteristics and tumorigenicity, and such an observation is further confirmed by cellular experiments both in vitro and in vivo. Our systematic analysis reveals that CNAs and epigenomic changes, rather than SNVs, are more likely to contribute to the phenotypic diversity among subpopulations in the tumor. These findings suggest that new therapeutic strategies targeting gene dosage and epigenetic modification should be considered in personalized cancer medicine. This culture model may be applied to the further identification of plausible determinants of cancer metastasis and relapse.

Optimization of Cell Lines As Tumour Models by Integrating Multi-Omics Data

In Search of the Perfect Model: How Cancer Cell Lines Relate to Native Cancers

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

How clinically relevant are prostate cancer cell lines? A comprehensive characterisation and multiomics comparison

Comparative Analysis And Integrative Classification Of Nc160 Cell Lines And Primary Tumors Using Gene Expression Profiling Data

Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping

Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data

Next-generation characterization of the Cancer Cell Line Encyclopedia

Cancer Cell Lines Are Useful Model Systems for Medical Research

Single Cell Multi-Omics Reveal Intra-Cell-line Heterogeneity Across Human Cancer Cell Lines

Multi-omics Analysis of Primary Cell Culture Models Reveals Genetic and Epigenetic Basis of Intratumoral Phenotypic Diversity.

Identifying Anti-Cancer Drug Response Related Genes Using an Integrative Analysis of Transcriptomic and Genomic Variations with Cell Line-Based Drug Perturbations.

A Clinical Genomics-Guided Prioritizing Strategy Enables Selecting Proper Cancer Cell Lines for Biomedical Research.

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types

Identifying cell lines across pan-cancer to be used in preclinical research as a proxy for patient tumor samples

Application status and optimization suggestions of tumor organoids and CAR-T cell co-culture models

Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles

Identification of Pan-Cancer Biomarkers Based on the Gene Expression Profiles of Cancer Cell Lines

From multi-omics integration towards novel genomic interaction networks to identify key cancer cell line characteristics

Drug Response Modeling across Cancers: Proteomics vs. Transcriptomics

Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer